Unlocking Curcumin's Untapped Potential in Drug DevelopmentUnlocking Curcumin's Untapped Potential in Drug Development
The network for creativity
Join 1.25M professional creatives like you
Connect with clients, get discovered, and run your business 100% commission-free
Creatives on Contra have earned over $150M and we are just getting started
Back to feedPost
Sudhir's avatar
Sudhir Ahluwalia
• Feb 6
Curcumin: A Case Study in Missed Translation
Curcumin, the active compound in turmeric, sits at the center of a modern paradox. Thousands of patents and an immense body of preclinical research highlight its anti-inflammatory, antioxidant, and anti-cancer potential—yet no curcumin-based drug has emerged from clinical trials.
The reason is structural, not botanical. Curcumin shows poor bioavailability, rapid metabolism, and formulation challenges that clash with the single-molecule drug model. Traditional systems never used turmeric in isolation, pairing it with fats and bioavailability enhancers.
Curcumin may not be a drug failure—but a signal that our development frameworks need rethinking.
#Curcumin #DrugDevelopment #NaturalProducts #ClinicalResearch #IntegrativeMedicine
AuthorshipResearchGhostwritingGoogle ScholarCanvaMicrosoft Word
Post image
Sudhir's avatar
Sudhir Ahluwalia
• Feb 12
Thank you Rubina for liking this post. I have written a couple of follow-up posts on curcumin. I can share these, in case this is something that interests you. I can share these as new posts. I will be delighted to take a look at some of your content too. Thanks. Sudhir
Back to feed
The network for creativity
Join 1.25M professional creatives like you
Connect with clients, get discovered, and run your business 100% commission-free
Creatives on Contra have earned over $150M and we are just getting started